drugset / Trial / NCT02806544
Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country
Phase 2
Completed
35 enrolled
Vanderbilt University
Instituto National de Cancerologia, Guatemala · collabWashington University School of Medicine · collab
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the feasibility and efficacy of neoadjuvant tamoxifen for patients with locally advanced hormone receptor positive breast cancer in a low/middle income country.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 20 mg | Oral |